<?xml version = '1.0' encoding = 'UTF-8'?>
<?xml-stylesheet href="/rss/styledrssBMC.css" type="text/css"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns="http://purl.org/rss/1.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:extra="http://www.biomedcentral.com/xml/schemas/extra/" xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/" xmlns:cc="http://web.resource.org/cc/">
	<channel rdf:about="http://www.biomedcentral.com/rss">
		<extra:info rdf:parseType="Literal">
			<html:div xmlns:html="http://www.w3.org/1999/xhtml" style="font:14px Verdana, Geneva, Arial, Helvetica, sans-serif">
				<html:span style="font-weight:bold">This is an RSS newsfeed from BioMed Central</html:span>
				<html:br/>
				<html:span style="font-size: 12px;">It is intended to be used with an RSS reader. For more information about RSS newsfeeds from BioMed Central, visit <html:br/><html:a href="http://www.biomedcentral.com/info/about/rss/" style="color:#3333CC; font-size:12px;">http://www.biomedcentral.com/info/about/rss/</html:a><html:br/>
				</html:span>
			</html:div>
		</extra:info>
		<title>Reproductive Biology and Endocrinology - Most viewed articles</title>
		<link>http://www.rbej.commostviewed/</link>
		<description>Most viewed articles in last 30 days from Reproductive Biology and Endocrinology (ISSN 1477-7827) published by 
				
				BioMed Central
		</description>
        <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
         <items>
            <rdf:Seq>
            
				    <rdf:li rdf:resource="http://www.rbej.com/content/1/1/110"/>			    
            
				    <rdf:li rdf:resource="http://www.rbej.com/content/4/1/59"/>			    
            
				    <rdf:li rdf:resource="http://www.rbej.com/content/2/1/14"/>			    
            
				    <rdf:li rdf:resource="http://www.rbej.com/content/5/1/9"/>			    
            
				    <rdf:li rdf:resource="http://www.rbej.com/content/3/1/28"/>			    
            
				    <rdf:li rdf:resource="http://www.rbej.com/content/1/1/54"/>			    
            
				    <rdf:li rdf:resource="http://www.rbej.com/content/6/1/33"/>			    
            
				    <rdf:li rdf:resource="http://www.rbej.com/content/1/1/111"/>			    
            
				    <rdf:li rdf:resource="http://www.rbej.com/content/6/1/21"/>			    
            
				    <rdf:li rdf:resource="http://www.rbej.com/content/6/1/34"/>			    
            
            </rdf:Seq>
        </items>
    </channel>
    
		<item rdf:about="http://www.rbej.com/content/1/1/110">
            
            <title>Assessment of fetal intracranial pathologies first demonstrated late in pregnancy: cell proliferation disorders</title>
			<description>A considerable number of central nervous system pathologies remain undiagnosed during the first two trimesters of pregnancy. This group of disorders includes anomalies of brain proliferation, migration and cortical organization. Due to the fact that a detailed ultrasound examination of the fetal brain is usually not performed during the third trimester the diagnosis of these disorders is usually only made in families with a previously affected child or in many cases be mere chance. In this article we review the feasibility of prenatal diagnosis of disorders of brain proliferation: microcephaly, macrocephaly, hemimegalencephaly and neoplastic and non-neoplastic abnormal cell types. We discuss the differential diagnosis and offer a stepwise approach to the diagnosis of the more common disorders.</description>
			<link>http://www.rbej.com/content/1/1/110</link>		
			<dc:creator>Gustavo Malinger, Dorit Lev and Tally Lerman-Sagie</dc:creator>
			<dc:source>Reproductive Biology and Endocrinology 2003, 1:110</dc:source>
			<dc:subject>Number of accesses: 997</dc:subject>
			<dc:date>2003-11-14</dc:date>
			<dc:identifier>doi:10.1186/1477-7827-1-110</dc:identifier>
			
			
							
					<prism:publicationName>Reproductive Biology and Endocrinology</prism:publicationName>
					
			
							
					<prism:issn>1477-7827</prism:issn>
					
			
							
					<prism:volume>1</prism:volume>
					
			
							
					<prism:startingPage>110</prism:startingPage>
					
			
							
					<prism:publicationDate>2003-11-14</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.rbej.com/content/4/1/59">
            
            <title>Molecular patterns of sex determination in the animal kingdom: a comparative study of the biology of reproduction</title>
			<description>Determining sexual fate is an integral part of reproduction, used as a means to enrich the genome. A variety of such regulatory mechanisms have been described so far and some of the more extensively studied ones are being discussed.For the insect order of Hymenoptera, the choice lies between uniparental haploid males and biparental diploid females, originating from unfertilized and fertilized eggs accordingly. This mechanism is also known as single-locus complementary sex determination (slCSD). On the other hand, for Dipterans and Drosophila melanogaster, sex is determined by the ratio of X chromosomes to autosomes and the sex switching gene, sxl. Another model organism whose sex depends on the X:A ratio, Caenorhabditis elegans, has furthermore to provide for the brief period of spermatogenesis in hermaphrodites (XX) without the benefit of the "male" genes of the sex determination pathway.Many reptiles have no discernible sex determining genes. Their sexual fate is determined by the temperature of the environment during the thermosensitive period (TSP) of incubation, which regulates aromatase activity. Variable patterns of sex determination apply in fish and amphibians. In birds, while sex chromosomes do exist, females are the heterogametic (ZW) and males the homogametic sex (ZZ). However, we have yet to decipher which of the two (Z or W) is responsible for the choice between males and females.In mammals, sex determination is based on the presence of two identical (XX) or distinct (XY) gonosomes. This is believed to be the result of a lengthy evolutionary process, emerging from a common ancestral autosomal pair. Indeed, X and Y present different levels of homology in various mammals, supporting the argument of a gradual structural differentiation starting around the SRY region. The latter initiates a gene cascade that results in the formation of a male. Regulation of sex steroid production is also a major result of these genetic interactions. Similar observations have been described not only in mammals, but also in other vertebrates, emphasizing the need for further study of both normal hormonal regulators of sexual phenotype and patterns of epigenetic/environmental disruption.</description>
			<link>http://www.rbej.com/content/4/1/59</link>		
			<dc:creator>Panagiota Manolakou, Giagkos Lavranos and Roxani Angelopoulou</dc:creator>
			<dc:source>Reproductive Biology and Endocrinology 2006, 4:59</dc:source>
			<dc:subject>Number of accesses: 738</dc:subject>
			<dc:date>2006-11-13</dc:date>
			<dc:identifier>doi:10.1186/1477-7827-4-59</dc:identifier>
			
			
							
					<prism:publicationName>Reproductive Biology and Endocrinology</prism:publicationName>
					
			
							
					<prism:issn>1477-7827</prism:issn>
					
			
							
					<prism:volume>4</prism:volume>
					
			
							
					<prism:startingPage>59</prism:startingPage>
					
			
							
					<prism:publicationDate>2006-11-13</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.rbej.com/content/2/1/14">
            
            <title>Fundulus heteroclitus gonadotropins.5: Small scale chromatographic fractionation of pituitary extracts into components with different steroidogenic activities using homologous bioassays</title>
			<description>Fractionation and characterization of gonadotropins (GtH) from Fundulus heteroclitus pituitary extracts were carried out using a biocompatible liquid chromatographic procedure (Pharmacia FPLC system). Chromatographic fractions were monitored for gonadotropic activities (induction of oocyte maturation and steroid production) using homologous follicle bioassays in vitro. Size-exclusion chromatography eluted gonadotropic activity in one major protein peak (Mr ~ 30,000). Anion-exchange and hydrophobic-interaction chromatography (HIC) yielded two distinct peaks of 17beta-estradiol (E2)- and 17alpha-hydroxy,20beta-dihydroprogesterone (DHP)-promoting activity with associated oocyte maturation. Two-dimensional chromatography (chromatofocusing followed by HIC) resolved pituitary extracts into two active fractions; both induced E2 synthesis, but one was relatively poor in eliciting DHP and testosterone production. Thus, using homologous bioassays, at least two quantitatively different gonadotropic (steroidogenic) activities: an E2-promoting gonadotropin (GtH I-like) and a DHP-promoting gonadotropin (GtH II-like), which has a lower isoelectric point but greater hydrophobicity than the former, can be distinguished from F. heteroclitus pituitaries by a variety of chromatographic procedures. This study complements previous biochemical and molecular data in F. heteroclitus and substantiates the duality of GtH function in a multiple-spawning teleost.</description>
			<link>http://www.rbej.com/content/2/1/14</link>		
			<dc:creator>Yu-Wai Peter Lin, Teresa R Petrino and Robin A Wallace</dc:creator>
			<dc:source>Reproductive Biology and Endocrinology 2004, 2:14</dc:source>
			<dc:subject>Number of accesses: 408</dc:subject>
			<dc:date>2004-03-24</dc:date>
			<dc:identifier>doi:10.1186/1477-7827-2-14</dc:identifier>
			
			
							
					<prism:publicationName>Reproductive Biology and Endocrinology</prism:publicationName>
					
			
							
					<prism:issn>1477-7827</prism:issn>
					
			
							
					<prism:volume>2</prism:volume>
					
			
							
					<prism:startingPage>14</prism:startingPage>
					
			
							
					<prism:publicationDate>2004-03-24</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.rbej.com/content/5/1/9">
            
            <title>Ovarian volume and antral follicle count for the prediction of low and hyper responders with in vitro fertilization</title>
			<description>Background:
The current study was designed to compare antral follicle count (AFC) and basal ovarian volume (BOV), the exogenous FSH ovarian reserve test (EFORT) and the clomiphene citrate challenge test (CCCT), with respect to their ability to predict poor and hyper responders.
Methods:
One hundred and ten regularly menstruating patients, aged 18&#8211;39 years, participated in this prospective study, randomized, by a computer designed 4-blocks system study into two groups. Fifty six patients underwent a CCCT, and 54 patients underwent an EFORT. All patients underwent a transvaginal sonography to measure the basal ovarian volume and count of basal antral follicle. In all patients, the test was followed by a standard IVF treatment. The result of ovarian hyperstimulation during IVF treatment, expressed by the total number of follicles, was used as gold standard.
Results:
The best prediction of ovarian reserve (Y) was seen in a multiple regression prediction model that included, AFC, Inhibin B-increment in the EFORT and BOV simultaneously (Y = -3.161 + 0.805 &#215; AFC (0.258-1.352) + 0.034 &#215; Inh. B-incr. (0.007-0.601) + 0.511 BOV (0.480-0.974) (r = 0.848, p &lt; 0.001). Univariate logistic regression showed that the best predictors for poor response were the CCCT (ROC-AUC = 0.87), the bFSH (ROC-AUC = 0.83) and the AFC (ROC-AUC = 0.83). Multiple logistic regression analysis did not produce a better model in terms of improving the prediction of poor response. For hyper response, univariate logistic regression showed that the best predictors were AFC (ROC-AUC = 0.92) and the inhibin B-increment in the EFORT (ROC-AUC = 0.92), but AFC had better test characteristics, namely a sensitivity of 82% and a specificity 89%. Multiple logistic regression analysis did not produce a better model in terms of predicting hyper response.
Conclusion:
In conclusion AFC performs well as a test for ovarian response being superior or at least similar to complex expensive and time consuming endocrine tests. It is therefore likely to be the test for general practise.</description>
			<link>http://www.rbej.com/content/5/1/9</link>		
			<dc:creator>Janet Kwee, Mariet E Elting, Roel Schats, Joseph McDonnell and Cornelis B Lambalk</dc:creator>
			<dc:source>Reproductive Biology and Endocrinology 2007, 5:9</dc:source>
			<dc:subject>Number of accesses: 375</dc:subject>
			<dc:date>2007-03-15</dc:date>
			<dc:identifier>doi:10.1186/1477-7827-5-9</dc:identifier>
			
			
							
					<prism:publicationName>Reproductive Biology and Endocrinology</prism:publicationName>
					
			
							
					<prism:issn>1477-7827</prism:issn>
					
			
							
					<prism:volume>5</prism:volume>
					
			
							
					<prism:startingPage>9</prism:startingPage>
					
			
							
					<prism:publicationDate>2007-03-15</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.rbej.com/content/3/1/28">
            
            <title>Role of oxidative stress in female reproduction</title>
			<description>In a healthy body, ROS (reactive oxygen species) and antioxidants remain in balance. When the balance is disrupted towards an overabundance of ROS, oxidative stress (OS) occurs. OS influences the entire reproductive lifespan of a woman and even thereafter (i.e. menopause). OS results from an imbalance between prooxidants (free radical species) and the body's scavenging ability (antioxidants). ROS are a double-edged sword &#8211; they serve as key signal molecules in physiological processes but also have a role in pathological processes involving the female reproductive tract. ROS affect multiple physiological processes from oocyte maturation to fertilization, embryo development and pregnancy. It has been suggested that OS modulates the age-related decline in fertility. It plays a role during pregnancy and normal parturition and in initiation of preterm labor. Most ovarian cancers appear in the surface epithelium, and repetitive ovulation has been thought to be a causative factor. Ovulation-induced oxidative base damage and damage to DNA of the ovarian epithelium can be prevented by antioxidants. There is growing literature on the effects of OS in female reproduction with involvement in the pathophsiology of preeclampsia, hydatidiform mole, free radical-induced birth defects and other situations such as abortions. Numerous studies have shown that OS plays a role in the pathoysiology of infertility and assisted fertility. There is some evidence of its role in endometriosis, tubal and peritoneal factor infertility and unexplained infertility. This article reviews the role OS plays in normal cycling ovaries, follicular development and cyclical endometrial changes. It also discusses OS-related female infertility and how it influences the outcomes of assisted reproductive techniques. The review comprehensively explores the literature for evidence of the role of oxidative stress in conditions such as abortions, preeclampsia, hydatidiform mole, fetal embryopathies, preterm labour and preeclampsia and gestational diabetes. The review also addresses the growing literature on the role of nitric oxide species in female reproduction. The involvement of nitric oxide species in regulation of endometrial and ovarian function, etiopathogenesis of endometriosis, and maintenance of uterine quiescence, initiation of labour and ripening of cervix at parturition is discussed. Complex interplay between cytokines and oxidative stress in the etiology of female reproductive disorders is discussed. Oxidant status of the cell modulates angiogenesis, which is critical for follicular growth, corpus luteum formation endometrial differentiation and embryonic growth is also highlighted in the review. Strategies to overcome oxidative stress and enhance fertility, both natural and assisted are delineated. Early interventions being investigated for prevention of preeclampsia are enumerated. Trials investigating combination intervention strategy of vitamin E and vitamin C supplementation in preventing preeclampsia are highlighted. Antioxidants are powerful and there are few trials investigating antioxidant supplementation in female reproduction. However, before clinicians recommend antioxidants, randomized controlled trials with sufficient power are necessary to prove the efficacy of antioxidant supplementation in disorders of female reproduction. Serial measurement of oxidative stress biomarkers in longitudinal studies may help delineate the etiology of some of the diosorders in female reproduction such as preeclampsia.</description>
			<link>http://www.rbej.com/content/3/1/28</link>		
			<dc:creator>Ashok Agarwal, Sajal Gupta and Rakesh K Sharma</dc:creator>
			<dc:source>Reproductive Biology and Endocrinology 2005, 3:28</dc:source>
			<dc:subject>Number of accesses: 321</dc:subject>
			<dc:date>2005-07-14</dc:date>
			<dc:identifier>doi:10.1186/1477-7827-3-28</dc:identifier>
			
			
							
					<prism:publicationName>Reproductive Biology and Endocrinology</prism:publicationName>
					
			
							
					<prism:issn>1477-7827</prism:issn>
					
			
							
					<prism:volume>3</prism:volume>
					
			
							
					<prism:startingPage>28</prism:startingPage>
					
			
							
					<prism:publicationDate>2005-07-14</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.rbej.com/content/1/1/54">
            
            <title>SPAM1 (PH-20) protein and mRNA expression in the epididymides of humans and macaques: utilizing laser microdissection/RT-PCR</title>
			<description>Background:
The Sperm Adhesion Molecule 1 (SPAM1) is an important sperm surface hyaluronidase with at least three functions in mammalian fertilization. Previously our laboratory reported that in the mouse, in addition to its expression in the testis, Spam1 is synthesized in the epididymis where it is found in membranous vesicles in the principal cells of the epithelium in all three regions. Since SPAM1 is widely conserved among mammals the aim of the study was to determine if its expression pattern in the epididymis is conserved in rodents and primates.
Methods:
We used laser microdissection (LM)/RT-PCR on frozen and paraffin-embedded epididymal sections of humans (n = 3) and macaques (n = 2) as well as in situ transcript hybridization to determine if transcripts are present in the epididymal epithelium. Western analysis and immunohistochemistry were used to detect and confirm the protein expression, and hyaluronic acid substrate gel electrophoresis analyzed its hyaluronidase activity. An in silico analysis of the proximal promoter of SPAM1 was also performed to identify relevant putative transcription binding sites for the androgen receptor.
Results:
We demonstrate that mRNA unique to SPAM1 is present in the principal cells of the epididymal epithelium in all individuals of both species studied. SPAM1 protein is present in all three regions of the epididymis, as well as the vas deferens, and is localized similarly to the transcripts. SPAM1 was shown to have hyaluronidase activity at pH 7.0. In the proximal promoter of SPAM1 were uncovered putative epididymal transcription factor binding sites including androgen receptor elements (AREs), consistent with epididymal expression.
Conclusions:
These findings allow us to conclude that epididymal SPAM1 is conserved in at least two mammalian classes, rodents and primates. This conservation of expression suggests that the protein is likely to play an important function, possibly in sperm maturation.</description>
			<link>http://www.rbej.com/content/1/1/54</link>		
			<dc:creator>Eric A Evans, Hong Zhang and Patricia A Martin-DeLeon</dc:creator>
			<dc:source>Reproductive Biology and Endocrinology 2003, 1:54</dc:source>
			<dc:subject>Number of accesses: 312</dc:subject>
			<dc:date>2003-08-06</dc:date>
			<dc:identifier>doi:10.1186/1477-7827-1-54</dc:identifier>
			
			
							
					<prism:publicationName>Reproductive Biology and Endocrinology</prism:publicationName>
					
			
							
					<prism:issn>1477-7827</prism:issn>
					
			
							
					<prism:volume>1</prism:volume>
					
			
							
					<prism:startingPage>54</prism:startingPage>
					
			
							
					<prism:publicationDate>2003-08-06</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.rbej.com/content/6/1/33">
            
            <title>Level set segmentation of bovine corpora lutea in ex situ ovarian ultrasound images</title>
			<description>Background:
The objective of this study was to investigate the viability of level set image segmentation methods for the detection of corpora lutea (corpus luteum, CL) boundaries in ultrasonographic ovarian images. It was hypothesized that bovine CL boundaries could be located within 1&#8211;2 mm by a level set image segmentation methodology.
Methods:
Level set methods embed a 2D contour in a 3D surface and evolve that surface over time according to an image-dependent speed function. A speed function suitable for segmentation of CL's in ovarian ultrasound images was developed. An initial contour was manually placed and contour evolution was allowed to proceed until the rate of change of the area was sufficiently small. The method was tested on ovarian ultrasonographic images (n = 8) obtained ex situ. A expert in ovarian ultrasound interpretation delineated CL boundaries manually to serve as a "ground truth". Accuracy of the level set segmentation algorithm was determined by comparing semi-automatically determined contours with ground truth contours using the mean absolute difference (MAD), root mean squared difference (RMSD), Hausdorff distance (HD), sensitivity, and specificity metrics.Results and discussionThe mean MAD was 0.87 mm (sigma = 0.36 mm), RMSD was 1.1 mm (sigma = 0.47 mm), and HD was 3.4 mm (sigma = 2.0 mm) indicating that, on average, boundaries were accurate within 1&#8211;2 mm, however, deviations in excess of 3 mm from the ground truth were observed indicating under- or over-expansion of the contour. Mean sensitivity and specificity were 0.814 (sigma = 0.171) and 0.990 (sigma = 0.00786), respectively, indicating that CLs were consistently undersegmented but rarely did the contour interior include pixels that were judged by the human expert not to be part of the CL. It was observed that in localities where gradient magnitudes within the CL were strong due to high contrast speckle, contour expansion stopped too early.
Conclusion:
The hypothesis that level set segmentation can be accurate to within 1&#8211;2 mm on average was supported, although there can be some greater deviation. The method was robust to boundary leakage as evidenced by the high specificity. It was concluded that the technique is promising and that a suitable data set of human ovarian images should be obtained to conduct further studies.</description>
			<link>http://www.rbej.com/content/6/1/33</link>		
			<dc:creator>Brennan J Rusnell, Roger A Pierson, Jaswant Singh, Gregg P Adams and Mark G Eramian</dc:creator>
			<dc:source>Reproductive Biology and Endocrinology 2008, 6:33</dc:source>
			<dc:subject>Number of accesses: 286</dc:subject>
			<dc:date>2008-08-04</dc:date>
			<dc:identifier>doi:10.1186/1477-7827-6-33</dc:identifier>
			
			
							
					<prism:publicationName>Reproductive Biology and Endocrinology</prism:publicationName>
					
			
							
					<prism:issn>1477-7827</prism:issn>
					
			
							
					<prism:volume>6</prism:volume>
					
			
							
					<prism:startingPage>33</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-08-04</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.rbej.com/content/1/1/111">
            
            <title>Thrombophilia and pregnancy</title>
			<description>Pregnancy is hypercoagulable state. The field of thrombophilia; the tendency to thrombosis, has been developed rapidly and has been linked to many aspects of pregnancy. It is recently that severe pregnancy complications such as severe preeclampsia intrauterine growth retardation abruptio placentae and stillbirth has been shown to be associated with thrombophilia. Recurrent miscarriage and has also been associated with thrombophilia. Finally, thromboembolism in pregnancy as in the non-pregnant state is linked to thrombophilia. In this review all aspects of thrombophilia in pregnancy are discussed, and also all prophylactic and therapeutic implications.</description>
			<link>http://www.rbej.com/content/1/1/111</link>		
			<dc:creator>Michael J Kupferminc</dc:creator>
			<dc:source>Reproductive Biology and Endocrinology 2003, 1:111</dc:source>
			<dc:subject>Number of accesses: 280</dc:subject>
			<dc:date>2003-11-14</dc:date>
			<dc:identifier>doi:10.1186/1477-7827-1-111</dc:identifier>
			
			
							
					<prism:publicationName>Reproductive Biology and Endocrinology</prism:publicationName>
					
			
							
					<prism:issn>1477-7827</prism:issn>
					
			
							
					<prism:volume>1</prism:volume>
					
			
							
					<prism:startingPage>111</prism:startingPage>
					
			
							
					<prism:publicationDate>2003-11-14</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.rbej.com/content/6/1/21">
            
            <title>Nutritional skewing of conceptus sex in sheep: effects of a maternal diet enriched in rumen-protected polyunsaturated fatty acids (PUFA)</title>
			<description>Background:
Evolutionary theory suggests that in polygynous mammalian species females in better body condition should produce more sons than daughters. Few controlled studies have however tested this hypothesis and controversy exists as to whether body condition score or maternal diet is in fact the determining factor of offspring sex. Here, we examined whether maternal diet, specifically increased n-6 polyunsaturated fatty acid (PUFA) intake, of ewes with a constant body condition score around the time of conception influenced sex ratio.
Methods:
Ewes (n = 44) maintained in similar body condition throughout the study were assigned either a control (C) diet or one (F) enriched in rumen-protected PUFA, but otherwise essentially equivalent, from four weeks prior to breeding until d13 post-estrus. On d13, conceptuses were recovered, measured, cultured to assess their capacity for interferon-tau (IFNT) production and their sex determined. The experiment was repeated with all ewes being fed the F diet to remove any effects of parity order on sex ratio. Maternal body condition score (BCS), plasma hormone and metabolite concentrations were also assessed throughout the study and related to diet.
Results:
In total 129 conceptuses were recovered. Ewes on the F diet produced significantly more male than female conceptuses (proportion male = 0.69; deviation from expected ratio of 0.5, P &lt; 0.001). Conceptus IFNT production was unaffected by diet (P > 0.1), but positively correlated with maternal body condition score (P &lt; 0.05), and was higher (P &lt; 0.05) in female than male conceptuses after 4 h culture. Maternal plasma hormone and metabolite concentrations, especially progesterone and fatty acid, were also modulated by diet.
Conclusion:
These results provide evidence that maternal diet, in the form of increased amounts of rumen-protected PUFA fed around conception, rather than maternal body condition, can skew the sex ratio towards males. These observations may have implications to the livestock industry and animal management policies when offspring of one sex may be preferred over the other.</description>
			<link>http://www.rbej.com/content/6/1/21</link>		
			<dc:creator>Mark P Green, Lee D Spate, Tina E Parks, Koji Kimura, Clifton N Murphy, Jim E Williams, Monty S Kerley, Jonathan A Green, Duane H Keisler and R Michael Roberts</dc:creator>
			<dc:source>Reproductive Biology and Endocrinology 2008, 6:21</dc:source>
			<dc:subject>Number of accesses: 274</dc:subject>
			<dc:date>2008-06-09</dc:date>
			<dc:identifier>doi:10.1186/1477-7827-6-21</dc:identifier>
			
			
							
					<prism:publicationName>Reproductive Biology and Endocrinology</prism:publicationName>
					
			
							
					<prism:issn>1477-7827</prism:issn>
					
			
							
					<prism:volume>6</prism:volume>
					
			
							
					<prism:startingPage>21</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-06-09</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.rbej.com/content/6/1/34">
            
            <title>In vivo quantification of embryonic and placental growth during gestation in mice using micro-ultrasound</title>
			<description>Background:
Non-invasive micro-ultrasound was evaluated as a method to quantify intrauterine growth phenotypes in mice. Improved methods are required to accelerate research using genetically-altered mice to investigate the interactive roles of genes and environments on embryonic and placental growth. We determined (1) feasible age ranges for measuring specific variables, (2) normative growth curves, (3) accuracy of ultrasound measurements in comparison with light microscopy, and (4) weight prediction equations using regression analysis for CD-1 mice and evaluated their accuracy when applied to other mouse strains.
Methods:
We used 30&#8211;40 MHz ultrasound to quantify embryonic and placental morphometry in isoflurane-anesthetized pregnant CD-1 mice from embryonic day 7.5 (E7.5) to E18.5 (full-term), and for C57Bl/6J, B6CBAF1, and hIGFBP1 pregnant transgenic mice at E17.5.
Results:
Gestational sac dimension provided the earliest measure of conceptus size. Sac dimension derived using regression analysis increased from 0.84 mm at E7.5 to 6.44 mm at E11.5 when it was discontinued. The earliest measurement of embryo size was crown-rump length (CRL) which increased from 1.88 mm at E8.5 to 16.22 mm at E16.5 after which it exceeded the field of view. From E10.5 to E18.5 (full term), progressive increases were observed in embryonic biparietal diameter (BPD) (0.79 mm to 7.55 mm at E18.5), abdominal circumference (AC) (4.91 mm to 26.56 mm), and eye lens diameter (0.20 mm to 0.93 mm). Ossified femur length was measureable from E15.5 (1.06 mm) and increased linearly to 2.23 mm at E18.5. In contrast, placental diameter (PD) and placental thickness (PT) increased from E10.5 to E14.5 then remained constant to term in accord with placental weight. Ultrasound and light microscopy measurements agreed with no significant bias and a discrepancy of less than 25%. Regression equations predicting gestational age from individual variables, and embryonic weight (BW) from CRL, BPD, and AC were obtained. The prediction equation BW = -0.757 + 0.0453 (CRL) + 0.0334 (AC) derived from CD-1 data predicted embryonic weights at E17.5 in three other strains of mice with a mean discrepancy of less than 16%.
Conclusion:
Micro-ultrasound provides a feasible tool for in vivo morphometric quantification of embryonic and placental growth parameters in mice and for estimation of embryonic gestational age and/or body weight in utero.</description>
			<link>http://www.rbej.com/content/6/1/34</link>		
			<dc:creator>Junwu Mu, John C Slevin, Dawei Qu, Sarah McCormick and S Lee Adamson</dc:creator>
			<dc:source>Reproductive Biology and Endocrinology 2008, 6:34</dc:source>
			<dc:subject>Number of accesses: 264</dc:subject>
			<dc:date>2008-08-12</dc:date>
			<dc:identifier>doi:10.1186/1477-7827-6-34</dc:identifier>
			
			
							
					<prism:publicationName>Reproductive Biology and Endocrinology</prism:publicationName>
					
			
							
					<prism:issn>1477-7827</prism:issn>
					
			
							
					<prism:volume>6</prism:volume>
					
			
							
					<prism:startingPage>34</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-08-12</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
		
	<cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
         <cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction"/>
         <cc:permits rdf:resource="http://creativecommons.org/ns#Distribution"/>
         <cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks"/>
	</cc:License>
</rdf:RDF>
